Skip to main content

Taking a deep breath…

The fervor over the soon-to-be-filmed movie “Albino Farm” continues to grow. I noticed today that the guestbook on the Web site had been shut down. I thought maybe it was just me, but several others have reported the same problem.

That’s okay. The point was to be noticed. Someone must have noticed.

In the past few days I’ve been able to take a deep breath about the movie. I’m still pissed as hell, to put it very bluntly, spitting mad and not about to let the issue drop – but once you’ve lit the fire you’ve got to give it just a little while to burn.

Given all the press generated about the Da Vinci Code last year, I find it hard to imagine the project’s principles were completely unaware that what they were doing might be offensive – but I guess it is possible.

I know the leadership of NOAH is now aware of the issue and so before posting some more links and ways that we can express our displeasure – I think we should give it a few days. Let’s see if NOAH has any luck opening a dialog with the film’s creators. Let’s see what they say. Simply removing “albinism” from the title and storyline would be enough to make me happy. If you look at the film’s concept art, the characters don’t even look like they’ve got albinism so maybe “albinism” isn’t really important to the storyline.

One of the people working on the film (not the director or producer) did e-mail someone from the Albinism International yahoo group back. He essentially said we were jumping to conclusions and if we’d read the script we wouldn’t feel this way.

I don’t think he gets it.

I find the film’s existing Web site incredibly offensive.

I would very much hope that after all the feedback left on the film’s guestbook, that its creators might issue a response on their Web site – but let’s see what happens. Let’s see if they do anything in the next few days. Let’s also see what NOAH decides to do.

I’ll keep my eye on the story.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria